2016
DOI: 10.1016/j.jprot.2016.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Identification of low-abundance proteins in serum via the isolation of HSP72 complexes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 27 publications
0
7
0
Order By: Relevance
“…Isolation of Hsp70‐binding proteins and identification with MS was carried out as previously described . For MS analyses, the cells were lysed in lysis buffer (50 mM HEPES [pH 7.5], 150 mM NaCl, 5 mM EDTA, and 1% NP‐40 containing 1 mM PMSF and a protease inhibitor cocktail).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Isolation of Hsp70‐binding proteins and identification with MS was carried out as previously described . For MS analyses, the cells were lysed in lysis buffer (50 mM HEPES [pH 7.5], 150 mM NaCl, 5 mM EDTA, and 1% NP‐40 containing 1 mM PMSF and a protease inhibitor cocktail).…”
Section: Methodsmentioning
confidence: 99%
“…For MS analyses, the cells were lysed in lysis buffer (50 mM HEPES [pH 7.5], 150 mM NaCl, 5 mM EDTA, and 1% NP‐40 containing 1 mM PMSF and a protease inhibitor cocktail). Cell lysates (500 μg protein) were precleared with inactivated NHS‐Sepharose beads (GE Healthcare) for 30 min at room temperature, and immunoprecipitated using NHS‐Sepharose beads conjugated to anti‐Hsp72 antibodies or rat IgG antibody at room temperature for 3 h, as previously described . The immunoprecipitates were then washed three times, and Hsp72 client proteins were eluted with 0.1 M glycine‐HCl (pH 2.0).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, its application to the detection of proteins present at low and ultralow concentrations in blood plasma or serum, which is of great importance for the search and verification of novel protein disease markers, is limited by the immense dynamic range of protein abundance levels that can span 12 orders of magnitude [2][3][4][5]. While the concentration of high-abundance proteins ranges in plasma from micrograms to tens of milligrams per milliliter, the upper concentration boundary for low-abundance proteins (LAPs) is usually set as 100 ng/mL [6][7][8]. LAPs include tissue-leakage proteins, which are of the most interest as putative biomarkers [9].…”
Section: Introductionmentioning
confidence: 99%
“…These antibodies have been used to immunoprecipitate and analyze chaperone complexes via high-resolution mass spectrometry. This methodology has been particularly effective in detecting low-abundance interactors of Hsp70 in a variety of conditions, allowing purification of complexes at native stoichiometry (Tanaka et al 2014;Tanaka et al 2016). Alternative strategies for chaperone interactome analysis have employed the use of an epitope-tagged bait protein in cell lines from a transient, CMV-driven expression plasmid.…”
Section: Introductionmentioning
confidence: 99%